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Fromthe
President

Work on our
Managed Care
project continues in an aggressive
fashion. The Managed Care
Committee has approved a Business
Plan, which has been endorsed by the
Medical Executive Committee. The
plan is available in the Medical Staff
Services office for all active staff
members to review.
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A subcommittee of the Managed Care
Committee has been appointed to work
on the Bylaws of our PHO. Ed Shay
of Saul, Ewing, Remick & Saul, a law
firm based in Philadelphia, is providing
legal counsel in the development of our
Bylaws. We are meeting weekly to try
to finalize the Bylaws of our Medical
Staff IPA as well as the Bylaws for the
PHO.
A Primary Care Committee has been
formed to review and discuss the
growing denruand for
capitatedlgatekeeper health care
systems. As you may know, the
Lehigh Valley Business Conference on
Health Care has contracted with
Capital Blue Cross/Keystone Health
Plan for point of service contracts.
Lehigh Valley Hospital, along with St.
Luke's Hospital and Sacred Heart
Hospital, has been chosen as one of the

three hospitals in our region for point
of service. As many of our primary
care physicians have been approached
by the plan administrators, we have
decided to schedule a meeting with the
Lehigh· Valley Business Conference,
Keystone, and our Primary Care
Committee to review the process and
especially the capitation!gatekeeper
model. We shall keep you informed of
this progress.

On another note, the search for a CEO
is underway. Several candidates have
been interviewed, and we are .
encouraged by the applicants.
Although we are still in the
interviewing process and no definite
decisions have been reached, it is good
to report that the process is in an active
stage.
I would like to express a note of thanks
to Charlie Gordon and the Information
Services staff in getting us all
comfortable with the new computer
system. They certainly have been
responsive to some of the changes that
have been suggested in helping to work
out the "kinks. • One note is that the
name plate will be changed by request
of nruany physicians. The admitting
doctor will now be identified. Please
note that they is not necessarily the
attending physician for that patient.
Continued on Page 2
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The attending physician, however, will
be identified in the computer and can
be changed by the Admitting Office.
The admitting physician identified on
the name plate will not be changed.
For our Quality Assurance Committee,
I would like to remind all physicians to
not only date their notes, but to time
them as well. This is to be done not
only on the progress notes, but also on
the order sheets as well.

Please keep me advised of your
suggestions and concerns. I appreciate
your input as we struggle through this
transitional phase.
Best wishes,

2:-:~o.~D.
Presideni, Medical Staff

New Outpatient Rehabilitation/Occupational Medicine
Facility Opens its Doors
In an effort to provide the most

comprehensive, high-quality outpatient
rehabilitation and occupational
medicine for the Lehigh Valley
community, Good Shepherd and
Lehigh Valley Hospital joined together
their facilities, talents, and resources to
form an independent corporation
known as Atrmity.
The goal of Affinity is to provide the

finest quality healthcare and
rehabilitation to persons who are
disabled or injured and to assist them
in achieving their maximum level of
performance.

The focus of the occupational medicine
program is the care and recovery of the
injured worker. The commitment of
the staff is to provide directed, quality
healthcare to the worker in a manner
which maximizes results and contains
costs. This approach benefits
everyone: workers, employers,
insurance companies, and referring
physicians.
Affinity is open from 7 a.m. to 7 p.m.,
Monday through Friday. For more
information, call Affinity at 402-9200.

licensed specialists achieve results by
using progressive, personali:red
rehabilitation programs. In the stateof-the-art facilities, located on the first
floor of 1243 S. Cedar Crest
Boulevard, Affinity offers a full
spectrum of quality therapy services
for all age groups. Treatment is
closely coordinated with the referring
physician.

)
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Observation Update

KePRO Korner

Please remember when your office is
scheduling a patient who you think
may require observation, the patient
should be scheduled as an
OUTPATIENT. They should not be
scheduled as an inpatient for
observation.

Reminder - once KePRO selects a
patient for review, all aspects (both
inpatient and outpatient) of that
patient's care will be reviewed for the
patient's life. Please date your History
& Physicals and OR consent forms to
avoid last lninute completion telephone
calls.

Also, KePRO is now beginning to
review Observation cases; therefore,
accurate, complete documentation is
critical.

Transfer Forms
It is essential for patients being

transferred to rehabilitation or skilled
nursing facilities that the Discharge
Medication section be filled out
completely and accurately specifying
the medications and dosages you wish
the patient to receive at the receiving
facility. Also, weight bearing status is
needed for orthopedic cases.

Completing these forms prior to
transfer will minimize the number of
telephone calls you receive from the
rehabilitation or skilled nursing facility.
In addition, KePRO is now monitoring
the adequacy of information sent with
patients at the time of discharge to a
rehabilitation or skilled nursing facility.

News from O.R. Scheduling
• Effective June 2, the incision time
for the first case on Tuesdays will be
at 8: 15 a.m. instead of 8 a.m. This
will allow physicians and nursing staff
to attend department meetings and
inservices.
• When scheduling patients for
surgical procedures, it is important to
provide the patient's last name, first
name, and middle initial, if known.
)

• If a patient has had a procedure
scheduled previously and the case was

delayed or canceled, the patient was
placed on a wait list. When
rescheduling the patient, please indicate
that the patient was originally
scheduled for a prOcedure on a specific
date and is being rescheduled. This
will eliminate the need to relay/repeat
the demographic information.
If you have any questions or concerns,

please contact Jody Porter,
Administrator, Perioperative Division,
at 402-8030.
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Updated Documentation Ale:
Physicians and Allied Health
Professionals are reminded that they
are required, in accordance with the
Medical Staff Bylaws, to provide the
Medical Staff Services office with
updated documentation for the
following: Pennsylvania licensure,
malpractice insurance, and D EA
certification.
While physicians had provided the
information which was current at the
time their reappointment applications
were submitted in March of 1992, it is
likely that one or more of the
documents has been renewed since
then. All physician licenses expired in
1992 (Osteopathic licenses in October,
and Allopathic in December). Many
Allied Health Professionals who are
licensed by the State renewed their
licenses ir: April. Also, since
insurance policies are renewed
annually, it is likely that policies have
been reissued since last provided to the
hospital. Please check your records.

Operations lmpror rnent -- _,
We can all participate in Op:.' .dons
Improvement in many ways.
A study published in the Journal of
LabortltOry Mlllicine (Vol. 23, No. 1,
January, 1992) confirmed that one of
the most significant causes of excessive
laboratory tests is the practice of daily
testing h · the absence of changes in test
values. :. ,znding orders for te-sting are
a major contributor to inefficient care.
Repeated tests which are normal or
abnormal and predictably won't change
dramatically add a great amount to the
cost of patient care.

If the renewal date is after March,
199.1, please forward copies as soon as
possible to the Medical Staff Services
office, 1243 S. Cedar Crest Boulevard,
Allentown, PA 18103.

Tt · Joint Commission for HealthCare
01 ~,.mizations (ICAHO) has announced
that it will be performiilg unannounced
surveys of hospitals, beginning with
those in the mid-point of their threeyear accremtation cycle. Lehigh
Valley .Hospital is now at the mid-point
of its cycle and anticipates a surprise
survey any time in the next few
months. The credentials files of
physicians and allied health
professionals are routinely scrutinized
by ICAHO to assure that these
documents are current. Therefore,
your promptness in providing the
needed updated information will be
greatly appreciated. 11 you have any
questions regarding this issue, please
c: · tact Elizabeth Emot, Medical Staff
r ·~Receptionist, at 4~-9850:

J Exce.t:dve Testing
., ·al o:e
~ ders
: circumstarc ·
ey r.
:::ated, in may . . ~~ tht;
!

give a gre.,
of stand~.

;~

.e hospitals have prohil
... ·.~ding orders. While L·
Hospital is not ready to t1
step at this time, we mus, ,
over inappropriate testing.

·ht to
le in
:not.
'!ll
.illey
;l

.atrol

Your attention to this issue is both
requested and appreciated. If you have
any questions, please contact David G.
Beckwith, Ph.D., Administrator,
Clinical Laboratory, at 402-8150.
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PHAMIS LastWord Changes and Tips
Thank you for your feedback.
Information Services has responded to
a concern raised by several physicians
and their office staffs regarding the
new format of the patient stamp plate.
On Wednesday, June 9, the new stamp
plate format was changed. The
patient's social security number was
replaced by the insurance group
number on all plates. In addition, a
new last line -- the admitting
physician's name preceded by ADM-was added to the inpatient, admitted
emergency department, and ambulatory
surgery patient plates. To
accommodate these changes, the
second line of the patient's address
needed to be omitted on all plates.
Due to these changes, Admitting will
once again create a new plate when a
patient is admitted from the Emergency
Department.

Also, if you haven't noticed, your
fingers are doing less work! The
screens that you helped to identify as a

"pain," i.e., the C\U'SOr defaulted in
inappropriate fields on different
screens, has also been fixed. The
following changes were also made on
June 9:
• COMMAND Screen - Inpatient/Y
moved to under the command field
• MPI - cursor defaults to second
field, instead of "Select for details"
• INPNAME look-up screen - cursor
defaults tO the last field rather than the
first ·

As a reminder, please try to remember
NOT to rely solely on the command
"LABR," especially if you would like
to review on-line Radiology and
Nuclear Medicine results along with
the inpatient current and up-to-date
Medication Profile. "MPI" does it all!
If you have any questions or concerns,
please contact Mary Sabo in _
Information Services at beeper 5696.

News from Research
A call for abstracts has been issued by
the American Society of Colon and
Rectal Surgeons for the Annual
Meeting which will be held on May 8,
1994 in Orlando, Fla. Submission due
date is November 1, 1993.

For instructions, forms, and further
information, please contact Kathleen
Moser in. the Research Department at
402-8889.

In addition, the American College of
Cardiology has issued a call for
abstracts for the 43rd Annual Scientific
Session to be held on March 13, 1994
in Atlanta, Ga. Submission due date is
September 10, 1993.
)
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LIFESAVERS

by Barbara A. Leri, Pharm.D., Clinical Pharmacy Services

Adenosine (AdenocardR): Remember 6-Flush-12
Flush
Adenosine is a Class ITa antiarrhythmic
agent available for the treatment of
Supraventricular Tachycardias (SVT).
Adenosine slows conduction time
through the AV node, can interrupt AV
nodal reentry pathways, and can.
restore normal sinus rhythm in patients
with Paroxysmal Supraventricular
Tachycardia (PSVT), including PSVT
associated with Wolf-Parkinson-White
(WPW) Syndrome.
Clinical trials have shown adenosine to
be as effective as verapamil in initial
conversion of PSVT. Adenosine is
considered to be the safer agent due to
its short half-life (approximately 10
seconds) and lack of hypotensive
effects. Its safety profile makes
adenosine an acceptable agent to use if
there is a question of SVT versus VT,
whereas, verapamil may be harmful.
Successful use of adenosine depends on
its proper administration. Adenosine is
administered as a 6mg RAPID IV
bolus over 1 to 2 seconds followed
immediately by a rapid Sec saline
flush. If unsuccessful, after 1 to 2
minutes, a second dose of 12mg is

administered mpidly over 1 to 2
seconds, aga~~- 1\Jllowed by a saline
flush. Anot:
'2mg dose may be
repeated if m.o;,. :.:ssary.
Side effects are common but transient
and include: chest pain, pressure or
tightness, heart block, SOB/dyspnea,
headache, lightheadedness, and nausea.
It is important to consider potential
drug interactions with each patient
being considered for treatment.
Dipyridamole (PersantineR) potentiates
the effects of adenosine and, therefore,
smaller doses of adenosine may be
effective. Carbamazepine (TegretolR)
may increase the degree of heart blocK
produced by adenosine.
Methylxanthines (Caffeine,
Theophylline, etc.) antagonize the
effects of adenosine and larger doses of
adenosine may be required for
effectiveness.
Therefore, it is the proper
administration in conjunction with
appropriate clinical judgment which
assures adequate and successful use of
adenosine within our institution.

Spend a Day With a Nurse
The Professional Nurse Council will
sponsor Spend a Day With a Nurse
on October 25, 1993. The purpose of
this program is to enhance
understanding of the roles and
responsibilities of the professional

nurse. Community members and
hospital staf·· ; ·; be given the
opportunity t ; ' nd three hours with a
professioru.J r, ·.. at Lehigh Valley
Hospital. Sta) t.med for more
in formation.
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Library News
If you are a current user of the

library's remote computer systems and
have not responded to the survey
mailed out in May, please return the
survey as soon as possible. Although
June 4 was the official deadline,
surveys will be accepted until the end
of June. At that time, the files will be
updated, and previous users who have
not responded will be omitted from the
active user file.

On another note, the Computer
Laboratory is forever changing, and
something "new" is always being
added. Please be sure to visit and keep
yourself updated as to what services
are available. There is a little bit of
something for everyone, and ideas and
suggestions are always welcome.
If you have any questions, please

contact Sherry Giardiniere in the
Library at 402-8406.

Pave the Way for Life
A special and somewhat unusual effort
on behalf of the John and Dorothy
Morgan Cancer Center has been
initiated by the Lehigh Valley Hospital
Trust Fund called Pave the Way for
Life.
This campaign is built around 4" x 8"
concrete paving bricks which will be
used to pave the floor of the patio at
the west end of the Cancer Center.
For a donation of $100, an individual,
family, organization, company, etc.,
may have a brick engraved with their
own name or in memory or in honor of
a loved one.

This brick campaign is intended to
accomplish several things - first, to
raise more cash support for the
building of the Cancer Center; second,
to provide for community-wide
involvement in the construction of the
Cancer Center; and finally, to create a
permanent means of recognition to all
who participate in the brick campaign.
For more information about this unique
program, contact Gail Evans, Director
of Operations, Lehigh Valley Hospital
Trust Fund, at 402-3031.

The commitment may be paid outright
or pledged over a three-year period.
All orders received by September 15,
1993, will have their bricks installed
before the building is opened and
dedicated this Fall. Bricks ordered
after that time will be held until the
Spring of 1994, when the remaining
bricks will be put in place.
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Name Change for AFFINITY FUND
In the April, 1993 issue of Medical
Sttifl Progress Notes, you may have
read about the AFFINITY FUND, a
long distance telephone service
provid~r, which can save you 5-35%
savings over most readily available
AT&T, MCI, and U.S. Sprint
programs.

doors at 1243 S. Cedar Crest
Boulevard. In order to avoid possible
confusion, the name of the hospitalsponsored AFFINITY FUND has been
changed to LVH Legacy Fund. All of
the benefits of this program -:- ..:.in the
same; the only thing that ch.:.li._,-. 1 i:·
the name.

Since that time, the new Good
Shepherd and Lehi?h Valley Hospital
outpatient rehabilitation and
occupational medicine facility -- also
known as Affinity - has opened its

Please note, however, that the parent
companv of our LVII Legacy Fund,
locatec
~cksonville, Fla., will
contim
~ under the name of the
Affinit)
,., Inc.

-······

Clinical Nutrition News

Indirect Calorimetry

substrate oxidation. This technology
permits individualization of nutrient
prescriptions.

Confused when deciding how many
calories to prescribe, especially with
parenteral and enteral nutritional
support? You're not alone! Nutrition
specialists are often stymied by this
dH:.:mma.

Patient populations and clinical
conditions that may benefit from
indirect calorimetry include:

by Judy Holaaka, R.D., M.S., C.N.S.D.

Although useful equations exist for

determination of energy needs 'in
healthy populations, calculations based
on these formulas do not apply in
critical illness or in the obese, elderly,
or children. Predictive formulas are
often inaccurate and may lead to
inappropriate and potentially
detrimental nutritional therapy.
In 1992, Lehigh Valley Hospital
initiated the use of indirect calorimetry
using a metabolic cart which measures
~.:. ~tual energy expenditure and

• morbid obesity/cachexia
• children (over 16 years); geriatrics
(over 70 years)
• amputees
• severe multitrauma and
neurotrauma: ISS > 25
• MSOF/sepsis
• renal failure
• hepatic failure
• pancreatitis

• HIV
• cancer with residual tumor

• COPD/failure to wean
• pharmacological paralysis/barbiturate
coma
Continued on Page 9
Page 8
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Indirect calorimetry is a method that
collects, measures, and analyses 02
consumed (VO~ and carbon dioxide
expired (VC~. These values are.
converted to resting energy expenditure
(REB) using the abbreviated WEIR
equation. The Respiratory Quotient
(RQ) Is derived from V02 and VC02.
RQ is a constant for a given substrate
oxidation. The RQ of fat is 0. 70; for
protein 0.80; for carbohydrate 1.0.
Total energy requirements are
determined by multiplying the REB by
1.10 - 1.30 or 1. 0 in chemical
paralysis/barbiturate coma. RQ results
are interpreted as:
0. 80-0.95

< 0.80

> 1.0

- mixed substrate
utilization
- appropriate nutritional
support
- may reflect
underfeeding
- consider increase
calories
- may reflect excess
calories or CHO
- consider decrease
CHO, calories or
increase lipid calories

Exercise caution, however.
Limitations exist in the use ·of indirect
calorimetry data. Metabolic
measurements reflect a brief period in
time and may not be representative of
the entire 24 hour period due to
fluctuations in metabolic rate. The
importance of monitoring nutritio~
parameters (pre-albumin, transfemn,
nitrogen balance) is imperative. Data
derived from the metabolic cart should
never replace the clinical judgment and
experience of the physician or exceed
recommended guidelines in critical
illness:
CHO: Not to exceed 4-5mg/Kg/
minutes
Lipids: 1.0-2.5gm/Kg
Protein: 1.5-2.5gm/Kg
Metabolic measurements are performed
by Respiratory/Pulmonary Services
Monday through Friday. A nutritional
assessment by a Registered Dietitian
will be completed when a study is
ordered.
The clinical protocol for indirect
calorimetry is available from the
Nutrition Support Service at 402-8440,
or Respiratory/Pulmonary Services at
402-8055.

Welcome, New Housestaff
Please join the Office of Education in
welcoming the 40 new housestaff who
will begin their resident education at
Lehigh Valley Hospital the week of
June 24. The new residents, along
with their dental, medical or
osteopathic school, include:
)

• Stuart M. Gutscho, D.M.D., University of
Pemll)'lvania Dental School
e Michael J. Parsons, D.M.D., Temple
University School of Dentistry
Continued on Page 10
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Medicine
• Robert J. Branton, D.O., Philadelphia
College of Osteopathic Medicine
• Andrew I. Cohen, D.O., Southeastern
UDiversity
• Theodore D. Conliffe, Ir., M.D.,
Halmemann UDiversity
• Edward C. Croen, M.D., Albert Einstein,

Bronx NY

• James M. Isemia, M.D., SUNY Buffalo School of Medicine
• Lorraine F. Iarrah, M.D., Medical College
of PennsylvaDia
• Thomas I. Lakata, D.O., UMDNJ-Robert
Wood Johnson
• Eugene W. Moretti, M.D., Temple
UDiversity
• Mary Beth O'Hara Mulhern, D.O.,
Philadelphia College of Osteopathic Medicine
• Shahzad Safdar, M.D., King Edward
Medical School, Pakistan
• Eric D. Shapiro, M.D., Temple UDiversity
• John L. Tiu, M.D., UDiversity of
Philippines
• James C. Wasson, M.D., Jefferson Medical
College

Surgery
• Stefano F. Agolini, M.D., UDiversity of

Virginia

• Gonzalo F. Albomoz, M.D., UDiversity San
Carlos, Guatemala
• Michael I. Devine, M.D., Jefferson Medical

College
• Paul M. Frassinelli, M.D., Jefferson
Medical College
• Patrick Gonzalez, M~D., Ponce School of
Medicine, Puerto Rico
• Dona C. Hobart, M.D., UDiversity of
Maryland
• Edward B. Petrasek, M.D., UMDNJ-Robert
Wood Johnson

Colon-rectal Surgery
• Fredric H. Itzkowitz, D.O., New York
College of Osteopathic Medicine
• Steven I. Waxenbaum, M.D.,
UMDNJ-Robert Wood Johnson

Plastic Surgery
• William H. Sabbagh, M.D., New York
Medical College
• Bryan V. Sonntag, M.D., Tulane UDiversity

Obstetrics and Gynecology
• Lori A. MagnessD.O., Philadelphia
College of Osteopathic Medicine
• Norman F. Navarro, M.D., Penn State
UDiversity of Medicine

Pathology
• Roger I. Schreck M.D., Case-Western
Reserve UDiversity

Rlldiology
• Dem U. Shippey, M.D., UDiversity of
Autonoma de Guadalajara
• Terry N. York, D.O., West Virginia School
of Osteopathic Medicine

• Dennis K. Chyung, M.D., Temple
UDiversity
• Kara A. Davis, M.D., MeharryMedical
College
• Donald T. Hall, M.D., Halmemann
UDiversity
• ToDi A. Hawley, M.D., HaJmemann
UDiversity ·
• SarojiDi Y. Hayne, M.D., Temple
_
UDiversity
• Glen J. HessingerM.D., Temple UDiversity
Sereaa A. Jung, M.D., Temple University
• Harpaul S. MehrokM.D., Hahnemann
University
• Vickie L. Varklet, M.D., Bowman Gray
School of Medicine
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Applicant Refe"al Service
Do you have a job opportunity in your
office? Are you looking for summer

help? If so, you may want to take
advantage of a free and confidential
service offered by Physician Office
Practice Services (POPS). The
Applicant Referral Service is designed
to provide physician offices with
information regarding individuals who
are interested in working in a
physician's or dental office. This
service is exclusive to members of
Lehigh Valley Hospital Medical Staff.
How does the Applicant Referral
Service work?

An Applicant Referral Form, designed
for physician office use, is available to
independent job applicants at a number
of locations including the Human
Resource Department of Lehigh Valley
Hospital and placement offices at local
collegesluniversities which provide
medical office education. The
completed Applicant Referral forms are
kept on file in the POPS Office
according to job classification and fulltime/part-time availability.

Job classifications on file currently
include billing clerks/managers,
typing/filing clerks, medical
receptionists, medical secretaries,
transcriptionists, office managers,
medical assistants, registered and
licensed practical nurses, EKG
technicians, phlebotomists, physician
assistants, and more.

Office. If they are .interested in
pursuing an applicant, they are given a
copy of the Applicant Referral form.
The original form remains on file for
six months, unless POPS is notified
that the applicant is no longer actively
seeking employment. The physician
office is responsible for contacting the
applicant directly and for all
employment issues.
Summer applicants include individuals
with pJ,"CVi.ous physician office, nursing,
pharmaceutical and/or hospital
experience. In addition, several
college students (whose fields of study
include Physician Assistant Programs
and Biology) are available for summer
employment.
Confidentiality

The names, addresses, and phone
numbers of Medical Staff members in
search of job applicants are kept
strictly confidential. For this reason,
inquiries from applicants are not
accommodated. As stated above, if a
physician or dentist is interested in
pursuing an application, they will
contact the individual directly.
For more information regarding the
Applicant Referral Service, or to set up
an appointment, please call Maria
Kammetler, POPS Representative, at
402-9857.

Medical Staff members, or their office
managers/designee, may review the
Applicant Referral Forms in the POPS
Page 11

Temporary Employment Exclusive Discount Program
As your employees begin to take their
summer vacations, you may want to
take ad"·antage of the exclusive
disco· nt offered to Medical Staff
merr
by MANPOWER Temporary
Emr
-~nt Service and Olsten Health
Care
ices. The two services were
chosom among 11 temporary
emp1; tent services that were
inve..o:.;: ;.:..ted by POPS for service,
quality and price. Each year, POPS
renegotiates the exclusive discount
program on behalf of the Medical
Staff.

your requirements would be for a
temporary employee. The
representative will take note of the
style of your office, special equipment
and computers you may have, and
other information that will ensure the
right employee match for yr·1r office.
The office profile may be · , at any
time, regardless of whetr
·re
currently in need of a te:
employee. In addition, h jv ... choose
to meet with a representative, you are
under ·n.o obligation to utilize their
services in the future.

In addition to receiving special
discounted prices from MANPOWER

For front office positions, please call
MANPOWER at 395-8900. For back
office positions, please contact Olsten
Health Care Services at 435-513L
1
Please mention that you are ?
\
Valley Hospital Medical S,.
.:c,
and you are participating in ~..
_tP.S
discount program.

and Olsten Health Care Services, you
are also eligible for a free office visit
from one of their representatives called
an "office profile." The representative
will briefly tour your office, meet the
staff, and talk with you regarding what

Congratulations/
Thomas D. Meade, M.D., orthopedic

surgeon, recently placed fourth in the
freestyle and butterfly in the East Coast
Masters Swimming Championships
held at Rutgers University.

David B. Sussman, M.D., orthopedic

surgeon, recently passed a voluntary
recertification examination given by the
American Board of Orthopedic
Surgery.

Publications, Papers and Presentations
James W. Jaffe, M.D., radiologist,
presented Ne' l"echniques in the
Treatment of . DeepVein Thrombo~
at Interventie .·. in Peripheral

Vascular Di~· .~e, a two-day course
held in Apri1 m St. Louis, Mo.

Dr. Jaffe also presented The Role of
'lbrombolytic Therapy in the
~ement

of Thrombosed Dialysis

Grafts at Grand Rounds for the
Division of Transplant:tion Services at
Washington Hospital center on June 4.
Continued on Page 13
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Alan B. Leahey, M.D.,
ophthalmologist, authored a paper titled
Chorioretinal Folds: A Comparison
of Unilateral and Bilateral Cases.
This article was published in the March
1993 issue of the Archives of
Ophtluilmology. This is the first
published study on a comparison of
chorioretinal folds in one eye versus
patients that have it in both eyes.
Bruce I. Rose, Ph.D., M.D., chief,
Section of Reproductive
Endocrinology, was recently informed
that his manuscript, The Use of a
Single Intrauterine Insemination of

Defrosted Cryopreserved Sperm for
Therapeutic Donor Insemination, has
been accepted for publication in the
International Journal of Fertnlty.
Michael H. UfbergM.D.,
gastroenterologist, and James F. Reed
III, Ph.D., Director of Research, coauthored an abstract, Presedation
Intravenous Hydrocortisone to
Reduce Diazepam-Induced Phlebitis,
which
recently published in the
May, .1993 edition of The American

was

Jounull of Gastroenterology.

Next Physician Office Practice Forum Scheduled
With today's fast paced schedules,
many offices are looking for ways to
increase productivity, improve
efficiency, cut costs, and save time! If
this sounds familiar, plan to attend the
next Physician Office Practice Forum
to be held on Thursday, June 24, from
noon to 2 p.m., in Classroom 1 of
Lehigh Valley Hospital, Cedar Crest &
1-78.

• exciting advances and advantages of
Electronic Media Claims (EMC) and
office automation

Amy K. Huck and Janet Brown from
Pennsylvania Blue Shield's Medicare
Electronic Services will be on hand to
provide important information
regarding office automation with
electronic billing and to answer
questions regarding this issue.

A demonstration of their Paperless
Claims Express (PCB) software will
also be provided.

Some of the issues to be discussed in
their presentation include:

)

• what is needed to bill electronically
• the many services offered by
Pennsylvania Blue Shield and Medicare
to support automation in physicians'
offices

As lunch will be prOvided,
preregistration is requested. To
register for the forum, please call Janet
M. Laudenslager in the POPS Office at
402-9853.
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* ·For Sale or

PHYSICIAN
PRAC'OOE
OPPORTlNTJES

Lease -- Springhouse
Professional Center, 1575 Pond
Road. Ideal for physician's office.
Approximately 2,500 sq. ft. Will
finish space to specifications.

*

For Sale or Lease -- Medicalprofessional office building on
South Cedar Crest Boulevard, just
minutes from Cedar Crest & 1-78
and 17th & Chew. 3,560 total sq.
ft. Ample parking, security/fire
alarms installed. Ideal for
physician group.

* For Sale -- Office building at
Northeast corner of 19th and
Turner Streets in Allentown.
Upper level - 2,400 + sq. ft., large
waiting room, two large
consultation rooms, five exam
rooms, etc. Lower level - 2,300 +
sq. ft. Parking lot for 16 cars.
*

For Lease -- Large, newly
remodeled, completely furnished
medical office space available for
subleasing/time share at Cedar
Crest Professional Park. Top of
the line telephone system.
Transcription and computer system
with electronic billing available.

* For Lease

-- Medical office
space located In Peachtree Office
Plaza in Whitehall. One suite with
1,500 sq. ft. (unfinished allowance available), and one
1,000 sq. ft. finished suite.

* For Lease -- Medical office
space located In Southe~st
Allentown near Mountainville
Shopping Center:
* For Lease -- Slots are currently
available for the Brown Bag suite
at Kutztown Professional Center.
* For Lea9e -- Share large medical
office near Cedar Crest & 1-78.
Fully furnish~d and staffed.
Multiple line phone system.
Computerize~ billing available.
* For· Lease -- Specialty practice
time-share sp <'~~ ce available in a
comprehensive health care facility.
Riverside Professional Center,
4019 Wynnewood Drive, Laurys
Station. Half- or full-day slots
immediately available.
* For Lease -- Share space in
MOB 1 on the campus of Lehigh
Valley Hospital, Cedar Crest & 178. Approximately 1,000 sq. ft.
Three exam rooms.
For more information or for
assistance in finding appropriate
office space to meet your needs,
contact Joe Pilla, POPS Rep, at
402-9856.

*

For Lease -- Medicalprofessional office space locate~
on Route 222 In Wescosville. ~· 0
1,000 sq. ft. offices available :.
combine to form larger suite.
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WHO'S NEW
The Who's New section of Medical
Stoff Progress Notes contains an
update of new appointments, address
changes, newly approved privileges,
etc.

Please remember that each department
or unit is responsible for updating its
directory, rolodexes, and approved
privilege rosters.

Medical Staff
Additional Privileges
Thomas D. DiBenedetto, MD

Department of Surgery
Division of Orthopedic Surgery
Endoscopic Carpal Tunnel Privileges
Peter A. Keblish, MD

Department of Surgery
Division of Orthopedic Surgery
Endoscopic Carpal Tunnel Privileges
Lester Rosen, MD

Department of Surgery
Division of Colon and Rectal Surgery
Laparoscopic Endoscopic Surgery
Privileges

Change of Status
William J. Bryan, DDS

Department of Dentistry
Division of Orthodontics
From Courtesy to Emeritus Courtesy

Charles W. ReningerMD

Department of Obstetrics and
Gynecology
Division of Obstetrics/Gynecology
Section of Benign Gynecology
From Active to Emeritus Active

Resignation
Rosalie R. Snyder, MD

Department of Medicine
Division of Family Practice

Address Change
James Balducci, MD

Lehigh Valley Hospital
17th & Chew
Perinatal Diagnosis & Testing Center
Center for Women's Medicine
1st Floor
402-7100

Dissolution of Partnership
Hamllton Internist Associates

(The partnenhip of Dn. Fnmkenfield,
Longeuhagen; and Wtlson continues but without
a group name.)

Practice Disassociation
. John M •. Kauffman, Jr., D.O.

(no longer 8880Ciated with Lehigh Valley Medical
A88ociates- James T. McNelis, D.O., and
Michael R. Goldner, D.O.)

Continued on Page 16

John R. Lapp, :MD

Department of Medicine
Division of Family Practice
From Courtesy to Emeritus Courtesy
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Continued from Page 15

Allied Health
Professionals
Appointment
Linda Barron, RN
Physician Extender
Professional RN

Resignation
Debra A. Kramer, CMA
Physician Extender
Technical
Medical Assistant
(ABC Pediatrics)

(Hematology Oncology Asstllliates)

Additional Privileges
Jeffrey W. Knauss, EdD
Associate Scientific
Psychologist
Attend Geriatric Population
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P&T Highlights
The foll~ng actions were
taken at the May 10, 1993,
Pharmacy and Therapeutics .·Committee Meeting
- James A. Giardina, Director
of Pharmacy

u1ary ..t1JAddinons
•

'"C'
£ QnTI

Floseljllbum (Mimoplu, Pllrlte-DIIvis) is the first
fiuoroquinolone cardiovascular agent to be
marlceted and is indicated for the management of
CHF in patients not responding to diuretics (+/digitalis), and in patients who are intolerant of, or
unresponsive to, a regimen including an ACE
inhibitor. F1osequina.n is a direct-acting mixed
arterial and venous vasodilator, which results from
the combined effects of fiosequinan and an active
metabolite. F1osequinan reduces both cardiac
preload and afterload; it also has some direct
chronotropic and possibly inotropic activities.
F1osequinan is rapidly and extensively absorbed
with an oral bioavailabilityof72%. Food reduces
the rate but not the extent of absorption and a
first pass affect further reduced the percent of
available drug. F1osequinan is rapidly metabolized in the liver to an active metabolite, with a
long half life. The halflifes of both compounds
are lengthened in CHF patients due to decreased
hepatic perfusion. Renal impairment halves the
clearance of the metabolite with much effect on
the parent oompound. An increased half life has
also been observed in elderly patients. Dosage
adjustment may therefOre be necessary in patients
with renal or hepatic impairment as well as in the
elderly. F1osequinan is gmenlly well tolerated
with the most COIJUIJQD adverse event being
headache, which gmenlly disappears after 1-2
weeks. Other adverse reactions include palpitation, tachycardia, nausea and vomiting, and taste
disturbances. F1osequinan causes significant
elevation in ALT and .ASf in some patients, and
it has anticoagulant activity which has caused
small, but significant inaeases in INR's, PT's and
A.PTrs. F1osequinan also inaeases potassium
excretion. Cross sensitivity with the quinolone
antibiotics has been reported and it should only
be given with caution in patients who have
demonstrated hypersensitivity to those agents.

Patients taking ACE inhibitors should be started

on a lower dose of flosequinan due to increased
hypotensive side effects. Patients on Warfarin
may require a dosage reduction given the anticoagulant effects noted above. All fiosequinan
patients should have their coagulation status
monitored during therapy. Other parameters
recommended fi>r monitoring include Blood
Pressure, heart rate and transaminase levels.
Preliminary dosing recommendations have been
decreased from 1OOmglday to 50-7 5mglday due
to increased mortality at the 1OOmglday dose.
F1osequinan is available as 50, 75 and 100mg
tablets; each costing $2.07.

SUIIUIITiptlm (Imitnx, Gilzxo) is a selective 5IIT10 serotonin receptor agonist indicated fi>r
acute treatment of migraine headache.
Sumatriptan produces brief and selective vasoconstriction of the arteriovenous anastomOSeS.
Sumatriptan is quiddy absorbed following
subcutaneous injection; onset of action is rapid
withheadachereliefobserved within 10-20
minutes. Sumatriptan is metabolized hepatically
and consequently should be given with caution iri
patients with liver dysfunction. No adjustment
appears necessary in rena11y impaired patients at
this time.
In comparative trials, Sumauiptan appeared to be
very effective in headache relief when oompared
1D placebo, although a large percentage (35%) of
the Sumastriptan patients reported recurrence.

The most common adverse effects ar dizziness,
malaise, fatigue, drowsiness, weakness, Bushing,
numbness, chest tightening or pressure, neck pain
or stiffness and a feeling of wannth or tingling.
All appear to be short lived. Taste and visual
disturbances have also been reported. Increased
BP has been reported and caution is recommended in hypertensive and elderly patients as
well as patients with symptomatic ischemic heart
Page 17

Tllble 1
POTASSIUM CHLORIDE INFUSION GUIDELINES
1. PeriphertJ Litu Aiministrlltitm - Munitond 17 Nt~~~-Monitored Unit.r
Method of

Adminiltntion

Maximum

Rate

Maximum

Concentration

Maximum

Amount/Container

IV Infusion
20mEqJhr 20mEq/100ml*/"'
80mEq
IV Bolus
20mEqJhr
20mEq/100ml**
20mEq
• In severe cases of fluid restriction, up to 30mEq(100ml may be given peripheraUy.
To reduce the risk of phlebitis, it is recommended that sterile water be utilized
as thediluent. especially when concentrations exceed 1mEq(10ml
•• All solutions with a concentration greater than 1mEq/10ml must be
administered via an electronic rate controlling device regardless of delivery
site.
Ret.rences:
1. Kruse JA, Carlson RW. Rapid Correction of Hypokalemia Using Concentrated
Intravenous Potassium Chloride Infusion. Arch Intern Med.199D;150:613·617.
2. Robinson DC, Cookson TL. Grisafe JA. Concentration Guidelines for Parenteral
Antibiotics in Fluid-Restricted Patients. Drug Intel! CUn Pharm. 1987;21:985·
989.
3. Highly Concentrated Potassium Chloride Injection. Product Information. Baxter.
1990.

Potassium Chloride
Infusion Guidelines

Table 1 depicts the revised guidelines fur Potassimn Chloride infusions. The key change is that
KO may be siven as 20mEq/100cc of Sterile
Water (SWI), if fluid restriction is a concern.
Recent data indicate that, by diluting KO in
Sterile Water as apposed m Dextrose or Saline, it
is less likely m.induce phlebitis. The Phannacy
and Nursing departments are currently working
out a~ to eliminate KQ vials from floor
stock and replacing them with premixed
miru'bags. It is recommended that the routine
concen1r1tion for peripheral use is 1OmEq/100ml
and that the 20mEq/100ml SWI should be
reserved fur patients who cannot tolerate the extra
fluid.

Changing Diluents

The Committee approved a chanae in diluent for
continuous infusion Magnesium Sulfate infusions
from OS 1/2 NSS m DSW.

Request Tabled for ~"'-;J'ow

Enoxaparin (Lovenox, Rhone-Pe.' . •7lC Rarer) is
the first low molecular heparin (.L. . ~ ·-.11)
approved in the U.S. hslabeled£;,·.,:..:ationisthe
prm:ntion ofDVT 1Dllowing hip replacement
surpy. Prelirr.i..-wy stUdies show that IMWH's
have a lower incidence of tbrombocyropenia than
regular heparin. The committee tabled this
request until it could pin more infixmatian imo
potential therapeutic uses for this apt as an
alternative to traditional heparin in aJ¥0Priate
patients.''

Protecting the Children

P &: T approved a policy, n:cormne;:.,ied by the
Health Department, requiring t.:·.::.t· ail medicatioo
(except samples in original padQg:.:,· given to
patients leaving the hospital (!' r:. C.:.inics, etc.)
must be provided in child pre . ..·o.~ainers unless
authorization is obtained fror ,'t<: patient/
guardian m do otherwise. T!l: rilicy will be
implemented in the next several months.

Fonnulaiy Additions
CoiUiuld Ft. .... ,

disease (peripheral vasocxmtrictioo and patients
with coronary disease (coronary constriction).
No drugintcnctions have been repot red as of yet.
However, cautioo should be used if the patient
has taken an ergot mnaining product within 24
hours ofSumaaiptan until the consequences of
this combination are known.

Pitients should be monitOred u relief of
sympmms within 10-30 minutes of therapy.
Treatment &ilures may require further medical

therapy cr .imatiption. The recommended dose
is 6mg as a subcuaneous injection, which is given
inm the deltoid musc:le or lateral aspect of the
thigh. Treatment should not exceed twO doses
per day (given no less than 1 hour apart). If no
relief is experienced after the initial dose, a second
dose should not be given. Sumaaiptan is marketed in a kit fOr patient self injectioo
Sumaaiptan oostS 525. 9016mg dose.
Page 18

)

J>rug Utilization
Evaluations (DUE)

P & T approved DUE aiteria ror the use of
Midazolam and Lorazepam continuous infusions, as well as Oral Ondansetron see Table 2
and3.

Data relative to use will be oollected against
these aiteria and discussed at future P & T
meetings.
In addition to these new aiteria, targeted
antibiotics were reviewed and are summarized
inTable4.

TABLE J

- ONiJANSETRON

Justification a) prevention of acute onset nausea and
vomiting associated with moderately
emetogenic chemotherapy regimens.
b) management of chemotherapy related,
) delayed onset nausea and vomiting refractory to standard anti-emetic regimens.
c) management of refractory radiation induced
nausea and vomiting.
d) management of oncology patients experiencing refractory nausea and vomiting as a
result of their disease state.
DosingPmmrtiora afchemothtrllJIJ inlluwJ 'llllfMttV
fXIIIIiting
a) first dcse (8mg) administered 30 minutes
prior to initiation of chemotherapy,

milowed by 8mg Q4H x 2 doses.
b)Subsequentdosesof8mg'TIDfilr 1-2 days
aftmo oompletion of chemotherapy.
TrrlltiMirt t{rrfrlldllfy ,.,.
a)8mg'TID
~
a) no adjustments recommended in the elderly
or renally impaired.
b) pediatrics (4-12y.o) 4mg'TID ·
c) hepatic dysfunction: in severe hepatic
)
insufficiency, a total dally dose of 8mg is not
exceeded.

TABLE 2

- LoRAZBPAM AND MmAZOLAM (W) INFusiON CRlTERL4.

1..orrzzqxlm
Justification- Continuous agitation control in aitical care setting.
Dosage- O.lmglml concentration
Dlluents- D5W, NSS
Dose -Initial- 0.2-lmglhr
Maintenance- Injected in increments of25% of the initial
maintenance dose used to reach sedative endpoint; slow
titration used, especially in elderly, chronically ill, or debilitated patient; additional d~ given only after thorough
clinical evaluation. Dose < 4mglhr.
Complications - Indicated by oversedationlrespiratory depression or flumazenil(Mazicon) usage.
MiU:I:oltlm
Justification- Continuous agitation control in aitical care setting.
Dosage - lmg/ml ooncentration
Dlluent-D5W
Dose -Initial-< 5mglhr
Maintenance - Injected in increments of 25% of the initial
maintenance dose used to reach sedative endpoint; slow
titration used, especially in elderly, chronically ill, or debilitated patient; additional doses given only after thorough
clinical evaluation. Dose< 4mglhr.
Complications - See above complications.
TABLE 4 TARGET A.NrmiO'llcs
IV~- Empiric use continues filr the majority of patients with

Length ofTherapy (L01) averaging 3 days. Route of Administration

change requests are being made on potential appropriate patients.
~ - 70% ofApil's usage was empiric with an avenge LOT of 4.75
days. This LOT is increased over March's nmnbers. To help C01Dlteract these trends, a chart memo was proposed which suggests conversion
to Piperac:illin in appropriaie clinical situations. This memo was
reviewed and accepted by the InCectiODS Disease PMsion.
~ Swgbl~- 57 patients were reviewed. Doses were
pen on callwithin 1-2.5 hours ofincision and a v.uietyofagents and
lengths of therapy were used. The recommendation to be talcen back to
S1Jl'8\:lYis that single dose prophylaxis with Ce&zolin (open and lap
biliary surgery) and Ce&zoliniMetrone or CefOtet:an +!-luminal
decontamination (colorectal surgery). Repeat dosing is only required in
prolonged cases and is dependent upon the kinetics of the agent chosen.
Hthese recommendations had been used, a cost analysis showed that
$7000/year in drug acquisition savings alone would be saved based on SO

cases/month.

Page 19

Non-Profit Urg.

u.a. Poetaae

LEHigHVAlLEY

PAID
Alentown, PA
Permit No. 1922

HOSPITAL

Cedar Crest & I-78
P.O. Box 689 .
Allentown, PA 18105-1556

Medical Staff ·
Progress Notes
Joseph A. Candio, M.D.
President, Medical Staff
John E. Castaldo, M.D.
President-elect, Medical Staff
John Jaffe, M.D.
Past President, Medical Staff
John W. Hart
Vice President
Rita M. Mest
Medical Staff Coordinator
Janet M. Laudenslager
Physician Office Practice
Services

Managing Editor

Medlcal Executive CommiJtee
Harry W. BuchanaD IV, M.D.
J01eph A. Caudio, M.D.
John E. Calltaldo, M.D.
Victor J. Celani, M.D.
Robert V. Cununiaga, M.D.
Carl F. D'Anielo, M.D.
R.obort B. Doll, M.D.
John D. Farrell, M.D.
John P. Fitzgibbona, M.D.
Michael H. Geller, M.D.
Mark A. Gittleman, M.D.
Jamea J. Goodreau, M.D.
Thomu A. Hutchinaon, M.D.
John Jaffe, M.D.
Micbael W. Kaufmann, M.D.
Glenn S. Kratzer, M.D.
Mark C. Lester, M.D.
Ronald A. LuiZ, M.D.
Alphonae A. Maffeo, M.D.
D. Lynn Morria, M.D.
Paul E. Nurick
Walter J. Oltunaki, M.D.
RobertJ. Oriel, M.D.
John 1. Shane, M.D.
John D. VanBralde, M.D.
Headley S. White, M.D.
JohnS. Ziegler, o.g.s.

Mallt:tll SIII/I ~ Nota
is paNishrcJ ........., to
iaform die LelliP Valley

u...-.

Meclcal sa.tr ad
employers~ ......... - -

awauiac tbeMec&ml swr,
Artidel sllould be suiJmifte

to .Jaaet M. , ..........

...,.... Ollice Pndice
Sa tiers, 1243 s. Cedar Cnst
Boalenrd, Alleatotm, PA
18113, bJ tbe lint of ada
.........
II ,.a baft DJ

questioas

about

tbe

wwiiddta, ....._ aD Ms.
, ......., . . 11t 412-t153.

